These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 6358542)
21. The prognostic significance of angina pectoris experienced during the first month following acute myocardial infarction. Jespersen CM Clin Cardiol; 1997 Jul; 20(7):623-6. PubMed ID: 9220178 [TBL] [Abstract][Full Text] [Related]
22. Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial. Byington RP; Curb JD; Mattson ME JAMA; 1985 Mar 22-29; 253(12):1733-6. PubMed ID: 3974051 [TBL] [Abstract][Full Text] [Related]
23. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. Lampert R; Ickovics JR; Viscoli CJ; Horwitz RI; Lee FA Am J Cardiol; 2003 Jan; 91(2):137-42. PubMed ID: 12521623 [TBL] [Abstract][Full Text] [Related]
25. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials? Otterstad JE; Ford I Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391 [TBL] [Abstract][Full Text] [Related]
26. Long-term propranolol therapy for angina pectoris. Warren SG; Brewer DL; Orgain ES Am J Cardiol; 1976 Mar; 37(3):420-6. PubMed ID: 816188 [TBL] [Abstract][Full Text] [Related]
27. Propranolol in acute myocardial infarction: the MILIS experience. Rude RE; Buja LM; Willerson JT Am J Cardiol; 1986 Apr; 57(12):38F-42F. PubMed ID: 2871744 [TBL] [Abstract][Full Text] [Related]
28. Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest. Gundersen T; Grøttum P; Pedersen T; Kjekshus JK Am J Cardiol; 1986 Jul; 58(1):20-4. PubMed ID: 3524181 [TBL] [Abstract][Full Text] [Related]
29. Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias. Morganroth J; Lichstein E; Byington R Prev Med; 1985 May; 14(3):346-57. PubMed ID: 3903736 [TBL] [Abstract][Full Text] [Related]
30. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Hansteen V; Møinichen E; Lorentsen E; Andersen A; Strøm O; Søiland K; Dyrbekk D; Refsum AM; Tromsdal A; Knudsen K; Eika C; Bakken J; Smith P; Hoff PI Br Med J (Clin Res Ed); 1982 Jan; 284(6310):155-60. PubMed ID: 6799077 [TBL] [Abstract][Full Text] [Related]
31. Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians. Research Committee of the Scottish Society of Physicians Br Med J; 1971 Dec; 4(5790):775-84. PubMed ID: 4943606 [TBL] [Abstract][Full Text] [Related]
32. Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience. Lichstein E; Morganroth J; Harrist R; Hubble E Circulation; 1983 Jun; 67(6 Pt 2):I5-10. PubMed ID: 6342839 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of propranolol therapy after acute myocardial infarction related to coronary arterial anatomy and left ventricular function. Jafri SM; Khaja F; McFarland T; Capone R; Dahdah S; Haywood J; Edmiston WA; Tilley B; Schultz L; Goldstein S Am J Cardiol; 1987 Nov; 60(13):976-80. PubMed ID: 3673915 [TBL] [Abstract][Full Text] [Related]
34. Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experience. Byington RP; Worthy J; Craven T; Furberg CD Am J Cardiol; 1990 Jun; 65(20):1287-91. PubMed ID: 2188492 [TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis. The Danish Study Group on Verapamil in Myocardial Infarction. Jespersen CM; Hansen JF; Mortensen LS Eur Heart J; 1994 Feb; 15(2):270-6. PubMed ID: 8005130 [TBL] [Abstract][Full Text] [Related]
36. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. Gibson RS; Boden WE; Theroux P; Strauss HD; Pratt CM; Gheorghiade M; Capone RJ; Crawford MH; Schlant RC; Kleiger RE N Engl J Med; 1986 Aug; 315(7):423-9. PubMed ID: 3526151 [TBL] [Abstract][Full Text] [Related]
37. Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial. Haywood LJ Am Heart J; 1984 Sep; 108(3 Pt 2):787-93. PubMed ID: 6148005 [TBL] [Abstract][Full Text] [Related]
38. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Chadda K; Goldstein S; Byington R; Curb JD Circulation; 1986 Mar; 73(3):503-10. PubMed ID: 3948357 [TBL] [Abstract][Full Text] [Related]
39. The Beta-Blocker Heart Attack Trial in perspective. Goldstein S Cardiology; 1983; 70(5):255-62. PubMed ID: 6141847 [TBL] [Abstract][Full Text] [Related]
40. Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia. Baber NS; Evans DW; Howitt G; Thomas M; Wilson T; Lewis JA; Dawes PM; Handler K; Tuson R Br Heart J; 1980 Jul; 44(1):96-100. PubMed ID: 7000100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]